A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil
PHASE1CompletedINTERVENTIONAL
Enrollment
195
Participants
Timeline
Start Date
January 31, 2014
Primary Completion Date
April 30, 2014
Study Completion Date
May 31, 2014
Conditions
Healthy Subjects
Interventions
DRUG
E2609
DRUG
itraconazole
DRUG
rifampin
DRUG
digoxin
DRUG
donepezil
Trial Locations (1)
78217
WCT Early Development, San Antonio
All Listed Sponsors
lead
Eisai Inc.
INDUSTRY
NCT02055703 - A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil | Biotech Hunter | Biotech Hunter